NASDAQ: WINT
Windtree Therapeutics Inc Stock Ownership - Who owns Windtree Therapeutics?

Insider buying vs selling

Have Windtree Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Craig FraserPresident and CEO2024-10-085,431$0.91
$4.94kBuy

1 of 1

WINT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when WINT insiders and whales buy or sell their stock.

WINT Shareholders

What type of owners hold Windtree Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lph Investments Ltd1,300.13%46,232,085$49.93MInsider
Lees Pharmaceutical Holdings Ltd488.50%17,370,770$18.76MInsider
China Cardiovascular Focus Ltd226.77%8,063,861$8.71MInsider
James Huang173.02%6,152,576$6.64MInsider
Panacea Venture Healthcare Fund I LP127.32%4,527,345$4.89MInsider
Ivy Blue Holdings Ltd121.96%4,336,790$4.68MInsider
Lph II Investments Ltd112.72%4,008,234$4.33MInsider
Center Laboratories Inc69.69%2,478,176$2.68MInsider
Robert J. Capetola12.27%436,417$471.33kInsider
Christopher J. Schaber6.55%232,771$251.39kInsider

1 of 3

WINT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
WINT0.33%99.67%Net Buying
DRMA0.84%85.19%
CDT12.56%87.44%Net SellingNet Buying
TOVX1.24%8.98%
TCRT0.25%99.75%Net BuyingNet Buying

Windtree Therapeutics Stock Ownership FAQ

Who owns Windtree Therapeutics?

Windtree Therapeutics (NASDAQ: WINT) is owned by 8.82% institutional shareholders, 2,666.72% Windtree Therapeutics insiders, and 0.00% retail investors. Lph Investments Ltd is the largest individual Windtree Therapeutics shareholder, owning 46.23M shares representing 1,300.13% of the company. Lph Investments Ltd's Windtree Therapeutics shares are currently valued at $50.39M.

If you're new to stock investing, here's how to buy Windtree Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.